• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

AcuCort

0.63 SEK+0.32 %9/7 17:25
Less than 1K followers

ACUC

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.32 %
-3.95 %
-3.36 %
+6.40 %
+5.33 %
-10.99 %
-28.92 %
-78.23 %
-75.24 %

AcuCort is a pharmaceutical company. The company develops and commercializes pharmaceuticals based on well-established substances with a focus on user-friendliness and ease of administration. The company's leading product is an oral film for the acute treatment of allergic reactions and other conditions with high medical demand. Products are aimed at patients and caregivers globally. AcuCort was founded in 2006 and is headquartered in Lund, Sweden.

Read more
Market cap
148.17M SEK
Turnover
36.31K SEK
Revenue
690K
EBIT %
-3,839.13 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12/8
2026

Interim report Q2'26

Press release2026-06-24 10:11

Investor Studios: AcuCorts VD har ordet live från San Diego klockan 17.00

AcuCort
Press release2026-06-17 10:33

AcuCort AB: AcuCort publishes newsletter with CEO update

AcuCort
Press release2026-06-17 10:33

AcuCort AB: AcuCort publicerar nyhetsbrev med VD-uppdatering

AcuCort

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-06-11 12:55

AcuCort to attend BIO International Convention in San Diego - focus on strategic partnering discussions

AcuCort
Press release2026-06-11 12:55

AcuCort deltar på BIO International Convention i San Diego - fokus på strategiska partneringdiskussioner

AcuCort
Press release2026-06-05 09:31

Investor Studios: AcuCorts VD om kommersialisering, partners och kommande milstolpar

AcuCort
Regulatory press release2026-05-27 17:15

Kommuniké från årsstämma i AcuCort AB

AcuCort
Press release2026-05-27 08:00

AcuCort AB: AcuCort publishes newsletter with CEO update

AcuCort
Press release2026-05-27 08:00

AcuCort AB: AcuCort publicerar nyhetsbrev med VD-uppdatering

AcuCort
Press release2026-05-05 10:29

Analyst Group: Aktieanalys på AcuCort - Genombrottsavtal i Europa och regulatorisk framdrift i USA

AcuCort
Press release2026-04-28 15:34

Analyst Group: Analyst Group kommenterar AcuCorts Q1-rapport

AcuCort
Press release2026-04-28 08:46

Investor Studios: AcuCorts VD Jonas Jönmark presenterar kvartalet live 13.00

AcuCort
Regulatory press release2026-04-28 08:30

AcuCort AB: AcuCort publicerar delårsrapport för första kvartalet 2026

AcuCort
Regulatory press release2026-04-24 16:00

Kallelse till årsstämma i AcuCort AB (publ)

AcuCort
Press release2026-04-16 16:06

AcuCort AB: AcuCort publicerar nyhetsbrev med VD-uppdatering

AcuCort
Press release2026-04-16 16:06

AcuCort AB: AcuCort publishes newsletter with CEO update

AcuCort
Regulatory press release2026-04-14 13:00

AcuCort AB: AcuCort publicerar årsredovisning för 2025

AcuCort
Press release2026-04-13 11:50

Analyst Group: Analyst Group kommenterar AcuCorts överenskommelse med FDA avseende iPSP

AcuCort
Regulatory press release2026-04-13 08:20

AcuCort AB: AcuCort och FDA överens om iPSP - viktigt steg mot marknadsgodkännande i USA

AcuCort
Regulatory press release2026-04-13 08:20

AcuCort AB: AcuCort and the FDA agree on iPSP - important step towards US market approval

AcuCort